Saw this on Twitter: Shares are trading at ~$7.00. Buyout offer was for $6.30/share + two $1.00/share CVRs.
Item 8.01 Other Events.
January 24, 2020, the U.S. Federal Trade Commission granted early
termination of the waiting period under the Hart-Scott-Rodino Antitrust
Act of 1976, as amended (the “HSR Act”), with respect to the pending
acquisition (the “Merger”) of Achillion Pharmaceuticals, Inc.
(“Achillion”) by Alexion Pharmaceuticals, Inc. (“Alexion”), pursuant to
Agreement and Plan of Merger, dated as of October 15, 2019, by and among
Alexion, Achillion and Beagle Merger Sub, Inc., a wholly owned
subsidiary of Alexion.
early termination of the waiting period under the HSR Act satisfies one
of the conditions to the closing of the Merger. On December 19, 2019,
Achillion’s stockholders voted to adopt the Merger Agreement at a
special meeting of stockholders held by Achillion. The closing of the
Merger remains subject to the satisfaction or waiver of other customary
closing conditions. The Merger is
expected to be consummated as soon as practicable.